Encompass Health Corp financial data

Symbol
EHC on NYSE
Location
Birmingham, AL
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 26 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 109% % -8.4%
Debt-to-equity 161% % -19%
Return On Equity 18% % 4.4%
Return On Assets 8.3% % 16%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 99,416,162 shares -1.3%
Common Stock, Value, Issued $1,200,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 100,500,000 shares 0.6%
Weighted Average Number of Shares Outstanding, Diluted 102,200,000 shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $5,935,200,000 USD 10%
General and Administrative Expense $236,200,000 USD 13%
Costs and Expenses $4,882,100,000 USD 8.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $953,000,000 USD 27%
Income Tax Expense (Benefit) $192,900,000 USD 28%
Net Income (Loss) Attributable to Parent $566,200,000 USD 24%
Earnings Per Share, Basic 5.62 USD/shares 24%
Earnings Per Share, Diluted 5.54 USD/shares 24%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $72,200,000 USD -15%
Accounts Receivable, after Allowance for Credit Loss, Current $613,400,000 USD 3.4%
Other Assets, Current $129,900,000 USD 5.9%
Assets, Current $905,900,000 USD 2.1%
Operating Lease, Right-of-Use Asset $212,600,000 USD 4.4%
Intangible Assets, Net (Excluding Goodwill) $308,300,000 USD 3.5%
Goodwill $1,317,600,000 USD 2.6%
Other Assets, Noncurrent $243,700,000 USD 11%
Assets $7,089,700,000 USD 8.5%
Accounts Payable, Current $178,200,000 USD 4.2%
Employee-related Liabilities, Current $243,700,000 USD 6.9%
Accrued Liabilities, Current $54,800,000 USD 75%
Liabilities, Current $836,400,000 USD -0.55%
Long-term Debt and Lease Obligation $2,447,200,000 USD 3.7%
Deferred Income Tax Liabilities, Net $126,800,000 USD 21%
Operating Lease, Liability, Noncurrent $196,600,000 USD 3.6%
Other Liabilities, Noncurrent $53,800,000 USD 3.9%
Liabilities $3,813,900,000 USD 3.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax $500,000 USD
Retained Earnings (Accumulated Deficit) $1,289,400,000 USD 62%
Stockholders' Equity Attributable to Parent $2,438,200,000 USD 18%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $3,217,500,000 USD 15%
Liabilities and Equity $7,089,700,000 USD 8.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 200,000,000 shares 0%
Common Stock, Shares, Issued 116,036,500 shares 0%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $102,900,000 USD -16%
Deferred Tax Assets, Valuation Allowance $21,400,000 USD 1.9%
Deferred Tax Assets, Gross $127,000,000 USD -2.8%
Operating Lease, Liability $223,100,000 USD 3.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $566,700,000 USD 24%
Lessee, Operating Lease, Liability, to be Paid $305,200,000 USD 2.8%
Operating Lease, Liability, Current $26,500,000 USD 0.76%
Lessee, Operating Lease, Liability, to be Paid, Year Two $42,900,000 USD 8.3%
Lessee, Operating Lease, Liability, to be Paid, Year One $39,500,000 USD 1.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.063 pure -1.6%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $82,100,000 USD 1.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three $41,900,000 USD 11%
Deferred Tax Assets, Operating Loss Carryforwards $5,500,000 USD -38%
Lessee, Operating Lease, Liability, to be Paid, Year Four $27,500,000 USD -25%
Additional Paid in Capital $1,869,600,000 USD 1.2%
Depreciation, Depletion and Amortization $327,900,000 USD 9.4%
Deferred Tax Assets, Net of Valuation Allowance $105,600,000 USD -3.6%
Share-based Payment Arrangement, Expense $56,500,000 USD 17%